One Stop Shop for All Your Market Research Reports

2015-2023 World Injectable Drug Delivery Market Research Report by Product Type, End-User / Application and Regions / Countries

Summary Injectable drug delivery is defined as administration of a drug or drugs directly into patient?s blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system. Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc) South America (Brazil, Argentina etc) Middle East & Africa (Saudi Arabia, South Africa etc) By Type Analgesics Antibiotics Immunosuppressive Agents Antihypertensive Agents By End-User / Application Aesthetics Autoimmune Diseases Hormonal Disorders Infectious Diseases Oncology Pain Management By Company Becton Dickinson and Company Baxter International Gerresheimer Pfizer Schott Sandoz Teva Pharmaceutical Industries Eli Lilly and Company Antares Pharma Eli Lilly & Company Hospira Novo Nordik Sanofi Terumo Corporation Unilife Corporation Zogenix Scandinavian Health
Table of Contents 1 Market Definition 1.1 Market Segment Overview 1.2 by Type 1.3 by End-Use / Application 2 Global Market by Vendors 2.1 Market Share 2.2 Vendor Profile 2.3 Dynamic of Vendors 3 Global Market by Type 3.1 Market Share 3.2 Introduction of End-Use by Different Products 4 Global Market by End-Use / Application 4.1 Market Share 4.2 Overview of Co
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 2800
Corporate User US $5600
About this Report
Report ID 188656
Category
  • Medical Devices
Published on 15-Dec
Number of Pages 169
Publisher Name HeyReport
Editor Rating
★★★★★
★★★★★
(13)